Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia

Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy

(2015) Sara J. Lim et al.   AMERICAN JOURNAL OF HEMATOLOGY

Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome

(2015) Paolo Strati et al.   AMERICAN JOURNAL OF HEMATOLOGY

How I treat refractory and early relapsed acute myeloid leukemia

(2015) F. Thol et al.   BLOOD

Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: Novel agents and approaches currently in clinical trials

(2015) Joshua P. Sasine et al.   BLOOD REVIEWS

Approach to patients with primary refractory acute myeloid leukemia

(2015) Robert J. Orlowski et al.   CURRENT OPINION IN HEMATOLOGY

Sorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutation

(2015) Smith Giri et al.   Journal of the National Comprehensive Cancer Network

Targeting FLT3 to treat leukemia

(2014) Heiko Konig et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Finite-Difference Time-Domain (FDTD) design of gold nanoparticle chains with specific surface plasmon resonance

(2014) Cristian Tira et al.   JOURNAL OF MOLECULAR STRUCTURE

Novel drugs for older patients with acute myeloid leukemia

(2014) G Montalban-Bravo et al.   LEUKEMIA

New agents: Great expectations not realized

(2013) Jeffrey E. Lancet   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Development of drug loaded nanoparticles for tumor targeting. Part 1: synthesis, characterization, and biological evaluation in 2D cell cultures

(2013) Mohammad H. El-Dakdouki et al.   Nanoscale

Live-cell monitoring of the glutathione-triggered release of the anticancer drug topotecan on gold nanoparticles in serum-containing media

(2012) Mira Kim et al.   CHEMICAL COMMUNICATIONS

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

(2012) R M Stone et al.   LEUKEMIA

Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro

(2011) Natalia Miklášová et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery

(2011) Haiqing Hu et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Tryptophan–Gold Nanoparticle Interaction: A First-Principles Quantum Mechanical Study

(2011) Prachi Joshi et al.   Journal of Physical Chemistry C

FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations

(2011) A. T. Fathi et al.   ONCOLOGIST

Photodynamic therapy and two-photon bio-imaging applications of hydrophobic chromophores through amphiphilic polymer delivery

(2011) Thibault Gallavardin et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

Properties and Applications of Colloidal Nonspherical Noble Metal Nanoparticles

(2010) Tapan K. Sau et al.   ADVANCED MATERIALS

Quantitative Evaluation of Cellular Uptake and Trafficking of Plain and Polyethylene Glycol-Coated Gold Nanoparticles

(2010) Christina Brandenberger et al.   Small

Adsorption of Pluronic F-127 on Surfaces with Different Hydrophobicities Probed by Quartz Crystal Microbalance with Dissipation

(2009) M. Reza Nejadnik et al.   LANGMUIR

Pluronics-Stabilized Gold Nanoparticles: Investigation of the Structure of the Polymer-Particle Hybrid

(2008) Kamil Rahme et al.   CHEMPHYSCHEM

Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers

(2008) Elena V. Batrakova et al.   JOURNAL OF CONTROLLED RELEASE